These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18940292)

  • 21. A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet.
    Ose L; Johnson-Levonas A; Reyes R; Lin J; Shah A; Tribble D; Musliner T;
    Int J Clin Pract; 2007 Sep; 61(9):1469-80. PubMed ID: 17655686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study.
    Lütjohann D; von Bergmann K; Sirah W; Macdonell G; Johnson-Levonas AO; Shah A; Lin J; Sapre A; Musliner T
    Int J Clin Pract; 2008 Oct; 62(10):1499-510. PubMed ID: 18822021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
    Rodríguez-Ferrero ML; Anaya F
    Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental lowering of low-density lipoprotein cholesterol with ezetimibe 20 mg vs 10 mg daily in patients receiving concomitant statin therapy.
    Ziada A; Schwarz UI; DeGorter MK; Tirona RG; Ban MR; Kim RB; Hegele RA
    Can J Cardiol; 2013 Nov; 29(11):1395-9. PubMed ID: 24182755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial low-density lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of ezetimibe.
    Ziajka PE; Reis M; Kreul S; King H
    Am J Cardiol; 2004 Mar; 93(6):779-80. PubMed ID: 15019893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
    Xydakis AM; Guyton JR; Chiou P; Stein JL; Jones PH; Ballantyne CM
    Am J Cardiol; 2004 Sep; 94(6):795-7. PubMed ID: 15374793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
    van der Graaf A; Cuffie-Jackson C; Vissers MN; Trip MD; Gagné C; Shi G; Veltri E; Avis HJ; Kastelein JJ
    J Am Coll Cardiol; 2008 Oct; 52(17):1421-9. PubMed ID: 18940534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of ezetimibe 40 mg vs. ezetimibe 10 mg in the treatment of patients with homozygous sitosterolaemia.
    Musliner T; Cselovszky D; Sirah W; McCrary Sisk C; Sapre A; Salen G; Lütjohann D; von Bergmann K
    Int J Clin Pract; 2008 Jul; 62(7):995-1000. PubMed ID: 18484971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe.
    Hegele RA; Guy J; Ban MR; Wang J
    Lipids Health Dis; 2005 Aug; 4():16. PubMed ID: 16098225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors.
    Chuang P; Langone AJ
    Am J Ther; 2007; 14(5):438-41. PubMed ID: 17890931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of a patient with a null low-density lipoprotein receptor mutation: a case report.
    Kolovou GD; Dedoussis GV; Anagnostopoulou KK; Hatzigeorgiou GCh; Salpea KD; Choumerianou DM; Rammos S; Mikhailidis DP; Cokkinos DV
    Angiology; 2006 Dec-2007 Jan; 57(6):729-32. PubMed ID: 17235114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous hypercholesterolaemia and ezetimibe: a case report.
    Hendriksz CJ; Norbury G; Tabrah S; Taylor A; Humphries SE
    Acta Paediatr; 2004 Feb; 93(2):280-2. PubMed ID: 15046291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients.
    Quarta CC; Potena L; Grigioni F; Scalone A; Magnani G; Coccolo F; Fallani F; Russo A; Branzi A
    J Heart Lung Transplant; 2008 Jun; 27(6):685-8. PubMed ID: 18503971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
    Crespo-Leiro MG; Paniagua MJ; Marzoa R; Grille Z; Naya C; Flores X; Rodriguez JA; Mosquera V; Franco R; Castro-Beiras A
    Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment.
    Bestehorn K; Völler H; Benecke H; Renner H; Karmann B; Wegscheider K
    Curr Med Res Opin; 2006 Apr; 22(4):631-9. PubMed ID: 16684423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Keleş T; Akar Bayram N; Kayhan T; Canbay A; Sahin D; Durmaz T; Ozdemir O; Aydoğdu S; Diker E
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):407-12. PubMed ID: 19103535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.